Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 14Unknown 6Terminated 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1CNS 1Breast 1

Conditions

Peripheral Nervous System Diseases 1Oligodendroglioma 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Edema 1Astrocytoma 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Vitamin B 12 × Clear all
NCT00402883 2021-11-09

Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

SCRI Development Innovations, LLC

Phase 2 Terminated
5 enrolled 6 charts
Thoracic

Lung Neoplasms

NCT02795572 2019-07-05

CIPN

AHS Cancer Control Alberta

Phase 2 Terminated
13 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00243022 2019-04-30

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Case Comprehensive Cancer Center

Phase 2 Terminated
12 enrolled 15 charts
CNSSarcoma

Astrocytoma, Brain Edema, Glioblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡